Elbasvir-Grazoprevir Zepatier
Glecaprevir-Pibrentasvir Mavyret
Ledipasvir-Sofosbuvir Harvoni
Ribavirin Copegus, Rebetol, Ribasphere
Sofosbuvir Sovaldi
Sofosbuvir-Velpatasvir Epclusa
Sofosbuvir-Velpatasvir-Voxilaprevir VoseviNot Found!
Unfortunately the page you requested was not found.
Perhaps you can find what you were looking for on this page.
Section Navigation
Section Navigation
- Module 6 Overview
Treatment of Key Populations and Unique Situations - 0%Lesson 1
Treatment of HCV in Persons with HIV CoinfectionActivities- 0%Lesson 2
Treatment of HCV in Persons with Renal ImpairmentActivities- 0%Lesson 3
Treatment of HCV in Persons with Substance UseActivities- 0%Lesson 4
Treatment of HCV in a Correctional SettingActivities- 0%Lesson 5
Management of Health Care Personnel Exposed to HCVActivities- 0%Lesson 6
Perinatal HCV TransmissionActivitiesTreatment of Key Populations and Unique Situations Overview4th Edition
Module Core Competency
Apply Evidence-Based HCV Treatment to Key Populations and in Unique Situations
Target Audience
Designed for clinicians who manage key populations of persons living with HCV and/or complex HCV-related unique treatment issues. Material covered is at an advanced level.Editors
H. Nina Kim, MD, MSc,H. Nina Kim, MD, MSc
Professor of Medicine
Division of Allergy & Infectious Diseases
University of WashingtonDisclosures: NoneMaria A. Corcorran, MD, MPHMaria A. Corcorran, MD, MPH
Assistant Professor
Division of Allergy & Infectious Diseases
University of WashingtonDisclosures: NoneFree CNE/CME
Module Lessons
1Lesson 1 Treatment of HCV in Persons with HIV Coinfection
- Learning Objectives
- Explain the impact of HIV on the progression of liver fibrosis in persons with untreated chronic HCV
- Describe current HCV treatment approaches in persons with HIV coinfection
- Discuss HCV treatment responses in persons with HIV and HCV coinfection compared with responses in persons with HCV monoinfection
- Summarize recommendations for treating HIV in persons with HCV and HIV coinfection
- List key drug interactions between HCV direct-acting antivirals and HIV antiretroviral medications
- Quick ReferenceTreatment of HCV in Persons with HIV Coinfection Core Concepts
- Activity 1B.DHHS Guidelines for HCV-HIV Coinfection
2Lesson 2 Treatment of HCV in Persons with Renal Impairment
- Learning Objectives
- Explain the impact of HCV on renal disease
- Summarize the main findings from HCV treatment studies in people with renal disease
- Discuss dosing of direct-acting antiviral medications in persons with chronic renal disease
- Describe appropriate HCV treatment in persons prior to renal transplantaton
- Summarize HCV treatment recommendations in persons following renal transplantation
- Quick ReferenceTreatment of HCV in Persons with Renal Impairment Core Concepts
- Activity 2B.GFR Calculator
3Lesson 3 Treatment of HCV in Persons with Substance Use
- Learning Objectives
- Discuss the prevalence of substance use among persons in the United States
- Describe HCV treatment responses in persons with substance use disorders compared with those who do not have substance use disorders
- Summarize HCV treatment eligibility in persons who have a past or current substance use disorder
- List support services and management strategies for persons with substance use disorders who have chronic HCV infection
- Explain the concept of HCV reinfection in persons who inject drugs
- Quick ReferenceTreatment of HCV in Persons with Substance Use Core Concepts
4Lesson 4 Treatment of HCV in a Correctional Setting
- Learning Objectives
- Describe HCV prevalence in the correctional setting
- Explain the difference between jails and prisons
- Summarize HCV screening recommendations in correctional settings
- State recommendations for HCV treatment eligibility in prisons
- Discuss HCV treatment approach in prisons
- Quick ReferenceTreatment of HCV in a Correctional Setting Core Concepts
5Lesson 5 Management of Health Care Personnel Exposed to HCV
- Learning Objectives
- List the definition of health care personnel
- Estimate the risk of HCV seroconversion after an occupational exposure to HCV that involves a needlestick injury
- Describe management of health care personnel exposed to HCV, based on type and nature of exposure
- Summarize monitoring and follow-up testing of health care personnel after occupational exposure to HCV
- Discuss the treatment approach for health care personnel who acquire HCV from an occupational exposure
- Quick ReferenceManagement of Health Care Personnel Exposed to HCV Core Concepts
6Lesson 6 Perinatal HCV Transmission
- Learning Objectives
- Describe the current guidelines for HCV screening in pregnant women
- Identify the risk of mother-to-child transmission of HCV and factors associated with increased risk of transmission
- Summarize the impact of HCV on pregnancy outcomes
- Describe interventions and/or prophylactic measures to reduce the risk of mother-to-child transmission of HCV
- List recommendations for HCV testing and management in infants born to mothers with HCV.
- Quick ReferencePerinatal HCV Transmission Core Concepts
- Background
- HCV Screening During Pregnancy
- Factors Associated with HCV Perinatal Transmission
- Impact of Chronic HCV Infection on Pregnancy
- Effect of Pregnancy on Chronic HCV
- Interventions to Prevent Mother-to-Child Transmission of HCV
- Safety of HCV Treatment During Pregnancy and Breastfeeding
- Monitoring of Pregnant Women with HCV
- Management of Infants and Children Born to Mothers with HCV Infection
- Summary Points
Share by e-mail
Check
-On-
Learning
QuestionsThe Check-on-Learning Questions are short and topic related. They are meant to help you stay on track throughout each lesson and check your understanding of key concepts.You must be signed in to customize your interaction with these questions.
- 0%Lesson 2
Funded by
Centers for Disease Control and Prevention Cooperative Agreement (CDC-RFA-PS21-2105)
Created at
University of Washington
Part of
IDEA Platform
CME provided byUniversity of Alabama Birmingham
CNE provided byUniversity of Washington School of Nursing
Copyright © 2024 Hepatitis C Online
Since you've received 80% or better on this quiz, you may claim continuing education credit.
You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.
Current Version: nhcvc-master-bb6cc37e-2024-10-29-225038